SCHEMBL4098996

SCHEMBL4098996

NC(N)=Nc1nc(-c2ccc(Cl)cc2)cs1

nearest known ligand 0.74

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 19/20 0.74
ATP4B P51164 19/20 0.74
NPC1 O15118 2/20 0.72
MAPT P10636 2/20 0.72
RAB9A P51151 2/20 0.72
GFER P55789 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL826833 0.98 ATP4A (0.75) ATP4AATP4BNPC1MAPTRAB9A
SCHEMBL28490654 0.84 ATP4A (0.74) ATP4AATP4BNPC1MAPTRAB9A
SCHEMBL823907 0.83 ATP4A (1.00) ATP4AATP4BNPC1MAPTRAB9A
Bromide SCHEMBL826907 0.83 MAPT (0.97) ATP4AATP4BNPC1MAPTRAB9A
Bromide SCHEMBL826727 0.83 ATP4A (0.72) ATP4AATP4BNPC1MAPTRAB9A
Hydrochloric Acid SCHEMBL826477 0.83 ATP4A (1.00) ATP4AATP4BNPC1MAPTRAB9A
Hydrochloric Acid SCHEMBL827560 0.83 ATP4A (0.91) ATP4AATP4BNPC1MAPTRAB9A
Bromide SCHEMBL825847 0.82 ATP4A (0.97) ATP4AATP4BNPC1MAPTRAB9A
Bromide SCHEMBL826782 0.82 ATP4A (0.69) ATP4AATP4BNPC1MAPTRAB9A
Bromide SCHEMBL825891 0.81 ATP4A (1.00) ATP4AATP4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine MALLE GERARD 2009-08-06 US disclosed
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE L'OREAL S.A. 2009-06-04 US disclosed
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin L'OREAL S.A. (FR) 2005-06-23 US disclosed
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine L'OREAL 2005-06-16 US disclosed
EP-1532963-A1 Composition for straightening the hair comprising at least one imine not being an hydroxide L'OREAL (FR) 2005-05-25 EP disclosed
EP-1532960-A1 Hair styling composition containing a non-hydroxide imine L'OREAL (FR) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE KRT18, INMT, INHA ATP4A 2618/4885ATP4B 3299/4885NPC1 4841/4885
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine KRT18, KIT, PRDM7 ATP4A 1552/4885ATP4B 2064/4885NPC1 4782/4885
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine KRT18, INHA, H1-5 ATP4A 1216/4885ATP4B 2135/4885NPC1 4747/4885
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin BHMT, KRT18, INMT ATP4A 1984/4885ATP4B 2672/4885NPC1 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.